Labetalol Hydrochloride Tablet, Film Coated
Product Images NDC 68001-381

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 68001-381). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Labetalol HCl Tablets Usp 100 mg 100 Tablets Label Rev 07 22

FDA Label Image

Labetalol HCl Tablets Usp 200 mg 100 Tablets Label Rev 07 22

This is a medication with the NDC code 68001-36200 containing Labetalol Hydrochloride in film-coated tablet form. It comes in a package with a suggested dosage for blood pressure and contains 200mg. The bottle should be kept tightly closed and away from children. The manufacturer is not clearly stated.*

FDA Label Image

Labetalol HCl Tablets Usp 300 mg 100 Tablets Label Rev 07 22

This is a medication description for a film-coated tablet with the NDC number 68001-36300. The tablets contain 300mg of Labetalol Hydrochloride. The usual recommended dosage instruction is not mentioned, and consumers are advised to check the package insert for more information. Manufactured by Zytus Uescences L. Ahmecibad, and distributed by R Buunabaates, the medication should be kept out of children's reach. The information also provides a warning to keep the medication tightly closed, as it contains powerful medication.*

FDA Label Image

Labetalol Hydrochloride Tablets (E4f35d97 B2d3 4f31 9606 Fd9d85b6cf7b 01)

The description is not-available.*

FDA Label Image

Labetalol HCl 100mg 100 Count Label (Rev 12-18.JPG)

This text appears to be a description of a medication called Labetalol Hydrochloride, USP. The medication is in tablet form and each tablet contains 100mg of Labetalol Hydrochloride. The recommended dosage is not mentioned and the reader is directed to refer to the package insert for further information. The medication should be stored between 20° to 25°C, in a tightly closed container away from children. There is also a lot number and expiration date stated.*

FDA Label Image

Labetalol HCl 200mg 100 Count Label (Rev 12-18.JPG)

This is a description of medication tablet packaging containing Labetalol Hydrochloride, USP 200mg manufactured by Cadila Health, based in India for BluePoint Laborataries. It provides information on the usual dosages and storage conditions. There are also instructions to keep the contents in a tightly closed container away from children. Lot number and expiration date are displayed.*

FDA Label Image

Labetalol HCl 300mg 100 Count Label (Rev 12-18.JPG)

Each film-coated tablet contains Labetalol Hydrochloride, USP of 300mg. The usual dosage can be found in the package insert, and the tablets should be stored at 20° to 25°C (68° to 77°F). They are tightly closed and dispensed in a tight, light-resistant container with a child-resistant closure as required. Keep this and all drugs out of the reach of children. This product was manufactured in Ahmedabad, India. The lot number is xio000x with the expiration date of DDMMMYYYY. The text instructs not to print on the non-varnished area. Lastly, the text contains the code ISR 0000000000000 and NDC 68001-383-00 RxOnly.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.